SCHEMBL18734934

SCHEMBL18734934

CCC(=O)NC(CSC(=O)CC(=O)C(=O)OC)C(=O)N(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18734935 0.90 KMT2A (0.32) —
SCHEMBL18734926 0.89 ALOX15 (0.31) —
SCHEMBL18735109 0.87 CYP2C9 (0.34) —
SCHEMBL18735399 0.87 CYP2C9 (0.34) —
SCHEMBL18735186 0.86 CYP2C9 (0.30) —
SCHEMBL18734939 0.86 — —
SCHEMBL18734931 0.84 — —
SCHEMBL18735395 0.83 SMN1; SMN2 (0.33) —
SCHEMBL18735396 0.83 SMN1; SMN2 (0.33) —
SCHEMBL17164978 0.83 CYP2C9 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback